Aurobindo Pharma Jumps 5% After Subsidiary Gets USFDA Nod for Osteoarthritis Pain Reliever
Shares of Aurobindo Pharma soared nearly 6% in the afternoon session on February 8 after the drugmaker said its downline subsidiary Aurolife Pharma had been...
